Slingshot members are tracking this event:
Keryx (KERX) Announces Phase III Results Evaluating Auryxia for the Treatment of Iron Deficiency Anemia in Patients With Stage 3-5 Non-Dialysis-Dependent Chronic Kidney Disease
Slingshot Insights Explained
Mar 29, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase Iii Results, Stage 3-5, Non-dialysis-dependent, Chronic Kidney Disease, Oral Iron-based Treatment, Iron Deficiency Anemia, Ferric Citrate